We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Latex Agglutination Test Identifies Bacterial Groups

By LabMedica International staff writers
Posted on 06 Dec 2011
The latex agglutination kit offers a faster streptococci-grouping solution than traditional methods for all clinically significant groups. More...


The kit is designed to improve workflow efficiencies since the nitrous acid extraction instantaneously extracts the cell antigens and the test does not require rehydration or incubation.

Beta-hemolytic streptococci may be identified rapidly and accurately according to the presence of specific cell wall antigens in a process called Lancefield Grouping. This process is most conveniently carried out using latex agglutination. To prepare the antigens for a latex agglutination reaction, an enzyme-mediated or nitrous acid extraction method may be used. Commercially available nitrous acid extraction kits are not traditionally capable of detecting group D antigen.

The PathoDxtra Strep Grouping Kit a latex agglutination kit from Thermo Fisher Scientific (Basingstoke, UK), detects groups A, B, C, D, F, and G antigen using a nitrous acid extraction method. The company report that a test panel of 131 beta-hemolytic streptococci have been assayed, including: Lancefield 21 group A, 27 B, 20 C , 23 D, 20 F, and 20 G. Thirty non-Lancefield group isolates were also tested, including: Streptococcus pneumoniae, S. viridans, Staphylococcus aureus, and Listeria monocytogenes. The kit was compared with other commercial kits.

All kits showed 100% accuracy in identifying all Lancefield group A and group C isolates. For the remaining isolates, PathoDxtra Strep Grouping Kit performed better than or comparable to all other products examined. The overall performance of kits that included a group D latex showed that PathoDxtra Strep Grouping Kit correctly identified 150/161 (93.2%) of the isolates tested. PathoDxtra Strep Grouping Kit agglutination reactions were consistently strong and exhibited a fast agglutination reaction for all Lancefield groups, providing results within 20 seconds.

Julie Elston, global product manager, immunodiagnostics, at Thermo Fisher said, "Acid extraction kits offered speed but did not detect group D strep reliably, while enzyme kits detected all groups but required rehydration and incubation steps, adding significant time to testing procedures. With PathoDxtra there is no compromise, this kits gives instantaneous extraction and detects all clinically significant streps reliably, including group D. It really couldn’t be simpler.”

Related Links:
Thermo Fisher Scientific



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.